Naepp Asthma Guidelines 2025. The use of single maintenance and reliever therapy (smart) for asthma is recommended for patients with moderate to severe persistent asthma and patients who have had a severe exacerbation in the prior year. The diagnosis and management of asthma is constantly evolving, and recently the national heart, lung, and blood institute published an updated guideline regarding various aspects of.

This guide is in pdf format and helpful for all users. The naepp 2020 and gina 2021 will equip providers with the.